You are here: Industry Insights > Breast Cancer

News List

EU invests €6.3m into cancer project led by Philips biospectrumasia
November 27, 2017
The project complements the €18.3m Cancer-ID project.
Obesity leads to larger, harder-to-detect tumours in breast cancer, study finds pharmafile
November 22, 2017
A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and harder to detect at early stage through conventional methods.
Novartis breast cancer medication Kisqali, struggling against Ibrance, finds niche in younger women fiercepharma
November 10, 2017
Novartis breast cancer medication Kisqali has struggled to gain traction in a field dominated by Pfizer blockbuster Ibrance. So it’s going where Ibrance hasn’t.
Combined therapies increase side effects for patients with advanced breast cancer europeanpharmaceuticalreview
November 06, 2017
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects…
Speedy review for AZ’ Lynparza in breast cancer pharmatimes
October 20, 2017
AstraZeneca’s and MSD’s Lynparza is being given a priority review by US regulators as a potential treatment for breast cancer, marking the first time a PARP inhibitor has been filed for an indication outside of ovarian cancer.
Breakthrough AI able to identify 97% of breast cancer risk pharmafile
October 19, 2017
Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose patients with breast cancer 97% of the time.
FDA accepts regulatory submission for Lynparza in metastatic breast cancer europeanpharmaceuticalreview
October 19, 2017
Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer…
AstraZeneca’s Faslodex receives CHMP opinion for advanced breast cancer treatment pharmaceufical-technology
October 18, 2017
Advanced / metastatic breast cancer refers to Stage III and IV breast cancer
Neratinib prevents Ras genes from causing cancer europeanpharmaceuticalreview
October 12, 2017
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development…
Unique tumour DNA found in blood to help detect breast cancer relapse biospectrumasia
October 09, 2017
Research uncovers unique tumour DNA found in blood which can be detected with a simple blood test for numerous clinical applications.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page